[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been considered ... Forced vital capacity; ICS: Inhaled corticosteroids ...

Current controller drugs for asthma include ICS, LABA, LTRA, omalizumab and theophylline. Current rescue drugs for asthma include short-acting β 2 agonists (SABA), short-acting muscarinic ...

and LABAs with LAMAs and ICS. Using these drugs in combination can often improve long-term control. Within each class of inhaled asthma medication are different drugs with different brand names.

Discover a study that compared the effectiveness of P043 versus omalizumab in managing uncontrolled allergic asthma.

LABA as monotherapy (without ICS) for asthma can increase risk of asthma ... should be instructed to discontinue the regular use of these drugs. Avoid Excessive Use of Trelegy Ellipta and Avoid ...

mometasone furoate given in a once-daily dose – showed that the two-drug combination performed better than the ICS alone in patients with poorly-controlled asthma. The duo improved lung function ...

The pharmacologic effects of beta 2-adrenoceptor agonist drugs, including salmeterol ... LABA monotherapy (without ICS) may increase risk of asthma-related events (death, hospitalizations ...

Among asthma patients infected with COVID-19, those who received the antiviral drug nirmatrelvir-ritonavir (Paxlovid) had ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This in-depth analysis shows that the Global Asthma and COPD Drugs Market, valued at ...

Novartis says that around a third of patients with asthma have symptoms that can’t be controlled using LABA/ICS dual therapy such as GSK’s older drug Seretide – which dominated the market ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...